Laparoscopic biliary atresia surgery in newborns reduces blood loss, improves jaundice recovery

Nagoya University researchers and their collaborators have found that minimally invasive laparoscopic surgery significantly reduces blood loss and improves jaundice recovery compared to traditional open surgery for treating biliary atresia-a serious liver condition in newborns. The study, published in Hepatobiliary Surgery and Nutrition, also found that high-dose steroid therapy after surgery does not necessarily improve outcomes for treating this condition.

Biliary atresia affects 1 in 15,000 newborns and is the leading cause of liver transplants in children. It occurs when bile ducts become blocked or do not develop properly, which prevents effective liver function and leads to progressive damage. What causes this blockage is unknown, and surgery is usually performed within the first two to three months of birth when the condition is diagnosed. 

Traditional surgery involves a large abdominal incision for direct access and has been the proven standard treatment for decades. The newer laparoscopic method uses several small incisions and a small camera to guide the surgery, offering benefits such as less tissue damage and smaller incisions. Both methods create new pathways for bile to flow from the liver when bile ducts are blocked by biliary atresia. 

Researchers analyzed data from 356 children who had surgery at about two months old, tracking their outcomes for an average of 13 years. Results showed that laparoscopic surgery reduced blood loss by 68%. Additionally, more patients had their jaundice symptoms clear after laparoscopic surgery (81%) compared to open surgery (64%). Jaundice, the yellow discoloration of skin and eyes, is caused by the accumulation of bilirubin, a waste product that the liver normally removes from the body. 

Patients who did not recover from jaundice after surgery typically received additional steroid therapy, resulting in higher doses for children who were not responding well to treatment. Drawing from 22 years of data, the researchers found that children receiving post-surgery steroid therapy above 90 mg/kg were 70% more likely to need a liver transplant. 

Steroid therapy is commonly used as post-operative care in many pediatric centers worldwide to reduce inflammation and help the liver produce bile, though protocols vary significantly between institutions. Our findings suggest that while steroid therapy itself may provide certain benefits, increasing the dose beyond a certain point does not necessarily improve outcomes." 

Dr. Yoichi Nakagawa, lead author, Graduate School of Medicine, Nagoya University 

Fifty percent of children who undergo surgery for biliary atresia will eventually need a liver transplant despite the procedure. Therefore, surgery is not a cure but rather a treatment that can delay the need for a transplant and allow children to keep their own liver for as long as possible. Although laparoscopic surgery takes about an hour longer, hospital stays and long-term liver survival remained the same for both types of surgery. 

The study represents the most detailed long-term analysis of surgical methods for this disease. It resolves uncertainty about laparoscopic surgery's long-term effectiveness, confirming that patients get the benefits of minimally invasive surgery-less blood loss, better jaundice clearance, and smaller incisions-without compromising success rates. 

Source:
Journal reference:

Nakagawa, Y., et al. (2025). Impact of laparoscopic Kasai portoenterostomy on long-term native liver survival in patients with biliary atresia: a multicentre propensity score-matched study. Hepatobiliary Surgery and Nutrition. doi: 10.21037/hbsn-2025-143. https://hbsn.amegroups.org/article/view/145969

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Understanding leptin's dual function in MAFLD pathogenesis